The New England journal of medicine, 2021-04, Vol.384 (17), p.1623-1634
- Sentilhes, Loïc
- Sénat, Marie V
- Le Lous, Maëla
- Winer, Norbert
- Rozenberg, Patrick
- Kayem, Gilles
- Verspyck, Eric
- Fuchs, Florent
- Azria, Elie
- Gallot, Denis
- Korb, Diane
- Desbrière, Raoul
- Le Ray, Camille
- Chauleur, Céline
- de Marcillac, Fanny
- Perrotin, Franck
- Parant, Olivier
- Salomon, Laurent J
- Gauchotte, Emilie
- Bretelle, Florence
- Sananès, Nicolas
- Bohec, Caroline
- Mottet, Nicolas
- Legendre, Guillaume
- Letouzey, Vincent
- Haddad, Bassam
- Vardon, Delphine
- Madar, Hugo
- Mattuizzi, Aurélien
- Daniel, Valérie
- Regueme, Sophie
- Roussillon, Caroline
- Benard, Antoine
- Georget, Aurore
- Darsonval, Astrid
- Deneux-Tharaux, Catherine
2021
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Sentilhes, Loïc
- Sénat, Marie V
- Le Lous, Maëla
- Winer, Norbert
- Rozenberg, Patrick
- Kayem, Gilles
- Verspyck, Eric
- Fuchs, Florent
- Azria, Elie
- Gallot, Denis
- Korb, Diane
- Desbrière, Raoul
- Le Ray, Camille
- Chauleur, Céline
- de Marcillac, Fanny
- Perrotin, Franck
- Parant, Olivier
- Salomon, Laurent J
- Gauchotte, Emilie
- Bretelle, Florence
- Sananès, Nicolas
- Bohec, Caroline
- Mottet, Nicolas
- Legendre, Guillaume
- Letouzey, Vincent
- Haddad, Bassam
- Vardon, Delphine
- Madar, Hugo
- Mattuizzi, Aurélien
- Daniel, Valérie
- Regueme, Sophie
- Roussillon, Caroline
- Benard, Antoine
- Georget, Aurore
- Darsonval, Astrid
- Deneux-Tharaux, Catherine
- Titel
- Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery
- Ist Teil von
- The New England journal of medicine, 2021-04, Vol.384 (17), p.1623-1634
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2021
- Quelle
- EZB-FREE-00999 freely available EZB journals
- Beschreibungen/Notizen
- In this trial involving women undergoing cesarean delivery (all of whom received prophylactic uterotonic medication), tranexamic acid treatment resulted in a significantly lower incidence of estimated blood loss greater than 1000 ml or red-cell transfusion by day 2 than placebo, but it did not reduce the risk of hemorrhage-related secondary clinical outcomes.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2028788Titel-ID: cdi_hal_primary_oai_HAL_hal_03238593v1
- Format
- –
- Schlagworte
- Acids, Administration, Intravenous, Adult, Antifibrinolytic agents, Antifibrinolytic Agents - adverse effects, Antifibrinolytic Agents - therapeutic use, Binding sites, Blood, Blood transfusion, Blood Transfusion - statistics & numerical data, Cesarean section, Cesarean Section - adverse effects, Childbirth & labor, Clinical trials, Consent, Double-Blind Method, Female, Hemorrhage, Humans, Life Sciences, Placebos, Population, Postpartum, Postpartum Hemorrhage - prevention & control, Pregnancy, Prevention, Pulmonary Embolism - etiology, Statistical analysis, Thromboembolism, Tranexamic Acid - adverse effects, Tranexamic Acid - therapeutic use, Vagina, Venous Thrombosis - etiology, Womens health